Refining scientific projects

Mintage Scientific's two current holdings operate in two different enterprises in terms of market and customer demands.

Subsidiary company Vicore Pharma AB develops and commercialises a new group of medical substances, while associate company I-Tech AB develops and commercialises a technology preventing foul growth on boat or ship hulls and marine installations.

Despite acting in highly dissimilar fields, I-Tech and Vicore Pharma have entered development phases where their needs of management, competence and expertise are of much the same character.

Mintage owns 100% of Vicore Pharma and 29% of I-Tech.